semaglutide for less than two years after stopping obesity drugs, weight and health issues return, study finds Ozempic® (semaglutide) GLP-1 RA for

Scientists analyzed electronic medical records for more than 73,000 people and found that after 5 years, GLP-1 use was linked to a significantly higher risk of developing osteoporosis, compared to those not taking the medication

It is advisable to write the date of first use on the pen to track the 6-week in-use period

but the glucose-lowering effect of SGLT2is is limited 14

The UK Summary of Product Characteristics (SmPC) for semaglutide, liraglutide and tirzepatide specifically states they should not be used during breast-feeding due to lack of human data

Effectiveness for weight loss Rybelsus and Ozempic arent approved for weight loss, but many people do lose weight while taking them

Slowed Gastric Emptying : By slowing down the rate at which food leaves your stomach, it helps control post-meal blood sugar spikes and keeps you fuller longer